The APOE ϵ4 allele is associated with lower selenium levels in the brain: implications for Alzheimer's disease

Document Type

Journal Article

Publication Title

ACS Chemical Neuroscience

Publisher

American Chemical Society

Place of Publication

United States

School

Collaborative Genomics Group / Centre of Excellence for Alzheimer's Disease Research and Care / School of Medical and Health Sciences

RAS ID

25386

Comments

Cardoso, B. R., Hare, D. J., Lind, M., McLean, C. A., Volitakis, I., Laws, S. M., . . . Roberts, B. R. (2017). The APOE ε4 allele is associated with lower selenium levels in the brain: Implications for Alzheimer’s disease. ACS Chemical Neuroscience, 8(7), 1459-1464. https://doi.org/10.1021/acschemneuro.7b00014

Abstract

The antioxidant activity of selenium, which is mainly conferred by its incorporation into dedicated selenoproteins, has been suggested as a possible neuroprotective approach for mitigating neuronal loss in Alzheimer's disease. However, there is inconsistent information with respect to selenium levels in the Alzheimer's disease brain. We examined the concentration and cellular compartmentalization of selenium in the temporal cortex of Alzheimer's disease and control brain tissue. We found that Alzheimer's disease was associated with decreased selenium concentration in both soluble (i.e., cytosolic) and insoluble (i.e., plaques and tangles) fractions of brain homogenates. The presence of the APOE ϵ4 allele correlated with lower total selenium levels in the temporal cortex and a higher concentration of soluble selenium. Additionally, we found that age significantly contributed to lower selenium concentrations in the peripheral membrane-bound and vesicular fractions. Our findings suggest a relevant interaction between APOE ϵ4 and selenium delivery into brain, and show changes in cellular selenium distribution in the Alzheimer's disease brain.

DOI

10.1021/acschemneuro.7b00014

Access Rights

subscription content

Link to Full Text

Share

 
COinS